Incidence of central nervous system metastases in patients with human epidermal growth factor recep- tor 2-positive metastatic breast cancer treated with trastuzumab: a meta-analysis

HIGHLIGHTS

• who: Xue Bai and colleagues from the General Hospital, Beijing, China have published the research: Incidence of central nervous system metastases in patients with human epidermal growth factor recep- tor 2-positive metastatic breast cancer treated with trastuzumab: A meta-analysis, in the Journal: (JOURNAL)

SUMMARY

Many studies have reported the incidence of CNS metastases in patients with MBC during trastuzumab treatment; however, the magnitude of the incidence substantially varies across the studies. The authors performed a systematic review to identify studies reporting the incidence of CNS metastases in patients with HER2-positive . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.